Figure 5
Figure 5. FBXO11 deletion in mice leads to lymphoproliferative disease. (A) Incidence of florid follicular hyperplasia (FFH), lymphoproliferative disease (LPD), and DLBCL in 17- to 18-month-old FBXO11+/+-Cγ1cretg/+ (WT), FBXO11fl/+-Cγ1cretg/+ (HET), and FBXO11fl/fl-Cγ1cretg/+ (KO) mice. N = number of analyzed mice; *P < .05 (1-way ANOVA). (B) Lymph node sections representative of no pathology (normal), FFH, LPD, and DLBCL were stained with hematoxilin/eosin (H&E), B220 (blue) and CD3 (brown), or BCL6 as indicated. Images were acquired using 10× and (for the insets) 20× objectives leading to an overall magnification of ×100 and ×200, respectively.

FBXO11 deletion in mice leads to lymphoproliferative disease. (A) Incidence of florid follicular hyperplasia (FFH), lymphoproliferative disease (LPD), and DLBCL in 17- to 18-month-old FBXO11+/+-Cγ1cretg/+ (WT), FBXO11fl/+-Cγ1cretg/+ (HET), and FBXO11fl/fl-Cγ1cretg/+ (KO) mice. N = number of analyzed mice; *P < .05 (1-way ANOVA). (B) Lymph node sections representative of no pathology (normal), FFH, LPD, and DLBCL were stained with hematoxilin/eosin (H&E), B220 (blue) and CD3 (brown), or BCL6 as indicated. Images were acquired using 10× and (for the insets) 20× objectives leading to an overall magnification of ×100 and ×200, respectively.

Close Modal

or Create an Account

Close Modal
Close Modal